Clinical Trials Logo

Clinical Trial Summary

Cancer Survivor Registry: The Breast Cancer M.A. P. (Mind Affects the Physical M.A.P.) Project to identify and help us understand the emotional and social needs of breast cancer survivors.


Clinical Trial Description

The Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project was the first registry of its kind to look at the emotional and social needs of individuals diagnosed with breast cancer and track how their needs changed throughout their cancer journey. Data will raise awareness and help develop programs to address the needs of breast cancer survivors. Findings from the Registry are disseminated online at www.CancerSupportCommunity.org/RegistryIndexReport2017 ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01295658
Study type Observational
Source Cancer Support Community, Research and Training Institute, Philadelphia
Contact
Status Completed
Phase
Start date May 2010
Completion date March 2013

See also
  Status Clinical Trial Phase
Completed NCT01127711 - Cohort of Swedish Men N/A
Recruiting NCT05299710 - Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Completed NCT01127698 - Swedish Mammography Cohort N/A
Completed NCT02734303 - Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test
Completed NCT01646437 - The International Polycap Study 3 (TIPS-3) Phase 3
Completed NCT01441674 - Animal Assisted Therapy in a Pediatric Setting Phase 1/Phase 2
Completed NCT04198896 - The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
Completed NCT01185470 - The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain Phase 2/Phase 3
Completed NCT00484016 - Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC N/A
Completed NCT03378895 - CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne N/A
Recruiting NCT06046066 - A Phase 1 Study of NM6603 in Advanced Solid Tumors Phase 1